Emirates 24|7
    Saturday, November 7, 2026 | 11:25 AM (Dubai)
    UAE Guide
    UAE e-scooter rules 2027: Minimum age, licence requirements and 6 safety rules riders must followDubai Access Club explained: Invite-only membership, five-year tourist visa and Dh2,000 credit for frequent visitorsUAE Labour Law: Can your employer deduct money from your salary? 7 situations where deductions are allowedOwn more than two cars? What you need to know about the new UAE traffic rules.UAE travel bans explained: Can a bounced cheque, unpaid debt or traffic fine stop you leaving the country?How to deregister your car in Dubai 2026: Documents, Dh120 fee and step-by-step RTA processUAE overtaking rules: 9 things drivers must check before changing lanesHow to extend a UAE visit visa 2026: Fees, documents and where to apply without leaving the countryHow to register Ejari and activate DEWA on DubaiNow: Steps, documents and fees for 2026Free AI courses in the UAE 2026: Four programmes to learn prompt engineering, generative AI and moreUAE Sanadak guide 2026: How to file a complaint against your bank or insurance company, and what to expectThink your rental contract is misleading? New Dubai ruling lets you cancel it before tenancy beginsAbu Dhabi Wildlife Response Network: How the new EAD initiative rescues and rehabilitates injured animalsDubai Fitness Challenge: 6,500 free workout sessions at Kite Beach, from yoga to surfingDubai Design Week 2026: Dates, tickets, highlights and what’s free at the 12th editionDoes your UAE health insurance end when you quit your job? Here’s what happens after visa cancellationPedestrian rules in the UAE: Six things you need to knowChanging jobs in the UAE? Your bank may use your gratuity to clear your debts – here’s how to stop itUAE driving test rules change from January 1, 2027: 6 mistakes that could mean an instant ‘fail’Dubai World Trade Centre's final bridge opens October 30: Six-minute journey cut to one minute
    Health

    US FDA probes tumour risk tied to Novartis gene therapy

    The Swiss drugmaker Novartis earlier in the day disclosed two cases in which tumours in children showed evidence of being linked to its gene therapy drug

    ReutersReuters
    2 min read
    Share
    Novartis said that it had received ⁠nine reports overall of tumours in patients previously treated with Zolgensma since the therapy was first approved in 2019. The logo of Swiss drugmaker Novartis for illustrative purposes. (Reuters)

    Novartis said that it had received ⁠nine reports overall of tumours in patients previously treated with Zolgensma since the therapy was first approved in 2019. The logo of Swiss drugmaker Novartis for illustrative purposes. (Reuters)

    Add Emirates 24|7 to your Google News
    Text Size:
    Google NewsFollow us on Google News
    Read Also

    New blood test matches gold standard for liver disease diagnosis

    England to use blood tests for early cancer detection in world first